0000000000461202

AUTHOR

Imre Ungi

showing 5 related works from this author

Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention. A Global Expert Consensus Document

2019

© American Heart Association, Inc.

medicine.medical_specialtyGuiding PrinciplesSCORING SYSTEMmedicine.medical_treatmentPerforation (oil well)percutaneous coronaryRevascularizationMULTICENTER CTO REGISTRYCARDIOVERTER-DEFIBRILLATOR RECIPIENTSmethodsLONG-TERM OUTCOMESPROCEDURAL OUTCOMESPhysiology (medical)treatment outcome.INTRAVASCULAR ULTRASOUNDmedicineCOMPUTED-TOMOGRAPHYIntensive care medicineinterventionHEALTH-STATUStreatmentVENTRICULAR-ARRHYTHMIASbusiness.industrypercutaneous coronary interventionStentPercutaneous coronary interventionReentryRETROGRADE APPROACHcoronary occlusionCoronary occlusionConventional PCIoutcomeCardiology and Cardiovascular Medicinebusiness
researchProduct

Global Chronic Total Occlusion Crossing Algorithm

2021

© 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC By-NC-ND License (http://creativecommons.org/licenses/by-nc-nd/4)

medicine.diagnostic_testAlgoritmosbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionGlobalState of the art reviewCollateral circulationTotal occlusionPercutaneous coronary interventionCatheterChronic total occlusionCoronary OcclusionIntravascular ultrasoundOcclusionAngiographyTreatment algorithmMedicineOclusão CoronáriaCardiology and Cardiovascular MedicinebusinessAlgorithmAlgorithms
researchProduct

Update in the Percutaneous Management of Coronary Chronic Total Occlusions

2018

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) has been rapidly evolving during recent years. With improvement in equipment and techniques, high success rates can be achieved at experienced centers, although overall success rates remain low. Prospective, randomized-controlled data regarding optimal use and indications for CTO PCI remain limited. CTO PCI should be performed when the anticipated benefit exceeds the potential risk. New high-quality studies of the clinical outcomes and techniques of CTO PCI are needed, as is the expansion of expert centers and operators that can achieve excellent clinical outcomes in this challenging patient and lesion subgroup. In…

medicine.medical_specialtyPercutaneousbusiness.industryPotential riskmedicine.medical_treatmentTreatment outcomePercutaneous coronary intervention030204 cardiovascular system & hematologyCABG = coronary artery bypass grafting CTA = computed tomography angiography CTO = chronic total occlusion IVUS = intravascular ultrasound MACE = major adverse cardiac event(s) MT = medical therapy OMT = optimal medical therapy PCI = percutaneous coronary intervention03 medical and health sciencessurgical procedures operative0302 clinical medicineChronic diseaseCoronary occlusionConventional PCImedicinecardiovascular diseases030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessProspective cohort studyIntensive care medicine
researchProduct

Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

2019

Gislason, Gunnar H/0000-0002-0548-402X; Malynovsky, Yaroslav V/0000-0002-9118-1104; Bhatt, Deepak L./0000-0002-1278-6245; Nikolaev, Konstantin/0000-0003-4601-6203; Sherwood, Matthew/0000-0002-4305-5883; Chumakova, Galina A/0000-0002-2810-6531; Raffel, Owen C/0000-0001-5470-7050; Leonardi, Sergio/0000-0002-4800-6132; Tse, Hung Fat/0000-0002-9578-7808; Reshetko, Olga/0000-0003-3107-7636; Pereira, Helder/0000-0001-8656-4883; Racca, Vittorio/0000-0002-4465-3789; Podoleanu, Cristian/0000-0001-9987-2519; Ersanli, Murat/0000-0003-1847-3087; Muenzel, Thomas/0000-0001-5503-4150; Sandhu, Manjinder/0000-0003-2538-2079; Taskinen, Marja-Riitta/0000-0002-6229-3588; bastos, jose/0000-0002-9526-3123; Manak…

MaleBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences.Cardiac & Cardiovascular SystemsMyocardial InfarctionUNIVERSAL DEFINITION030204 cardiovascular system & hematologyTHERAPYDISEASEchemistry.chemical_compound0302 clinical medicineCardiac and Cardiovascular Systems030212 general & internal medicineMyocardial infarctionProspective Studies1102 Cardiorespiratory Medicine and HaematologyOxygen supplyKardiologiBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti.CHOLESTEROLMiddle AgedMI typesCardiologyLDL Cholesterol LipoproteinsFemaleCardiology and Cardiovascular MedicineLife Sciences & Biomedicinemedicine.medical_specialty610ODYSSEY OUTCOMES InvestigatorsAntibodies Monoclonal HumanizedCLASSIFICATION03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansddc:610Alirocumab ; MI types ; Mortality ; PreventionMortalityMETAANALYSISAlirocumabAgedScience & TechnologyTask forceCholesterolbusiness.industryEVOLOCUMABPrevention1103 Clinical SciencesCholesterol LDLmedicine.diseaseEvolocumabchemistryCardiovascular System & HematologyCardiovascular System & CardiologyHuman medicinebusinessAlirocumab
researchProduct

Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review

2021

© 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC-BY-NC-ND license.

Coronary Occlusionpercutaneous coronary interventionHumanstreatment algorithmglobalCoronary Angiographychronic total occlusionAlgorithms
researchProduct